We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
Get the latest on Cellectar Biosciences' Q3 2025 earnings, EMA progress for iopofosine, clinical pipeline updates, and strategic outlook.
Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback